Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of GSK Plc ADR (NYSE: GSK) was $36.2 for the day, down -0.30% from the previous closing price of $36.31. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 3.34 million shares were traded. GSK stock price reached its highest trading level at $36.615 during the session, while it also had its lowest trading level at $36.19.
Ratios:
Our analysis of GSK’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.54. For the most recent quarter (mrq), Quick Ratio is recorded 0.58 and its Current Ratio is at 0.87. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.16.
On April 15, 2025, Exane BNP Paribas started tracking the stock assigning a Neutral rating and target price of $35.25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 27 ’24 when GSK plc bought 2,791,930 shares for $8.00 per share. The transaction valued at 22,335,440 led to the insider holds 16,775,691 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GSK now has a Market Capitalization of 76315754496 and an Enterprise Value of 170281680896. As of this moment, GSK’s Price-to-Earnings (P/E) ratio for their current fiscal year is 18.79, and their Forward P/E ratio for the next fiscal year is 7.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 5.401 whereas that against EBITDA is 19.677.
Stock Price History:
The Beta on a monthly basis for GSK is 0.51, which has changed by -0.07819241 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, GSK has reached a high of $44.67, while it has fallen to a 52-week low of $31.72. The 50-Day Moving Average of the stock is -6.87%, while the 200-Day Moving Average is calculated to be -2.19%.
Shares Statistics:
GSK traded an average of 5.40M shares per day over the past three months and 6553010 shares per day over the past ten days. A total of 2.04B shares are outstanding, with a floating share count of 2.02B. Insiders hold about 0.00% of the company’s shares, while institutions hold 18.19% stake in the company. Shares short for GSK as of 1749772800 were 16477295 with a Short Ratio of 3.43, compared to 1747267200 on 16757180. Therefore, it implies a Short% of Shares Outstanding of 16477295 and a Short% of Float of 0.8099999999999999.
Dividends & Splits
With its trailing 12-month dividend rate of 0.62, GSK has a forward annual dividend rate of 1.61. Against a Trailing Annual Dividend Yield of 0.017075185The stock’s 5-year Average Dividend Yield is 4.76. The current Payout Ratio is 94.89% for GSK, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-05-16. Stock splits for the company last occurred on 2022-07-22 when the company split stock in a 1226:1000 ratio.
